[HTML][HTML] ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

F Zhong, S Liu, Y Li, G Li, M Liu, J Wang, W Cui… - Lipids in Health and …, 2022 - Springer
Background It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome.

F Zhong, S Liu, Y Li, G Li, M Liu, J Wang… - Lipids in Health and …, 2022 - go.gale.com
Background It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

F Zhong, S Liu, Y Li, G Li, M Liu, J Wang, W Cui, Y Suo… - 2022 - agris.fao.org
Background It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

F Zhong, S Liu, Y Li, G Li, M Liu, J Wang… - Lipids in Health and …, 2022 - search.proquest.com
Background It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

F Zhong, S Liu, Y Li, G Li, M Liu… - Lipids in health …, 2022 - pubmed.ncbi.nlm.nih.gov
Background It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

ANGPLT3 Impacts Proteinuria and Hyperlipidemia in Primary Nephrotic Syndrome

F Zhong, S Liu, Y Li, J Wang, W Cui, Y Suo, X Gao - 2021 - researchsquare.com
Background: It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome.

F Zhong, S Liu, Y Li, G Li, M Liu, J Wang… - Lipids in Health and …, 2022 - europepmc.org
Background It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome.

F Zhong, S Liu, Y Li, G Li, M Liu… - Lipids in Health & …, 2022 - search.ebscohost.com
Background: It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …

[HTML][HTML] ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

F Zhong, S Liu, Y Li, G Li, M Liu… - Lipids in Health …, 2022 - lipidworld.biomedcentral.com
It is unclear why primary nephrotic syndrome (PNS) patients often have dyslipidemia.
Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an important …

[HTML][HTML] ANGPTL3 impacts proteinuria and hyperlipidemia in primary nephrotic syndrome

F Zhong, S Liu, Y Li, G Li, M Liu, J Wang… - Lipids in Health and …, 2022 - ncbi.nlm.nih.gov
Background It is unclear why primary nephrotic syndrome (PNS) patients often have
dyslipidemia. Recent studies have shown that angiopoietin-like protein 3 (ANGPTL3) is an …